SELLAS Life Sciences Group (SLS)
Develops licensed oncology candidates GPS and SLS009 for cancer indications.
$11.88
vs last close−0.14 (−1.16%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 39.26% | 73.04M shares | |
|---|---|---|---|
| 234 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 1.95% | 3.62M shares | |
| 8 holders · as of Jun 18, 2026 | |||
| Other | ≈ 58.79% | 109.37M shares | |
| remainder | |||
186.03M company shares as of Sep 18, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (201.95M in the company's Sep 23, 2026 report, 186.03M elsewhere); stakes use the report.
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
234 holders · 73.04M shares · 69 new positions · 150 increased · 33 reduced · 25 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.07M | 8.10% | +2.87M | Aug 7, 2026 |
| State Street Corp | 13.00M | 6.99% | +4.60M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 8.23M | 4.42% | +700.2K | Aug 13, 2026 |
| Geode Capital Management, LLC | 4.88M | 2.63% | +971.6K | Aug 12, 2026 |
| Anson Funds Management LP | 4.50M | 2.42% | +4.50Mnew | Aug 13, 2026 |
| Jones Financial Companies LLLP | 2.30M | 1.24% | +629.5K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 2.16M | 1.16% | +698.3K | Aug 13, 2026 |
| Susquehanna International Group, LLP | 2.05M | 1.10% | +1.65M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| State Street Corporation | 7.00% | 13.00M | 13G | Aug 7, 2026 |
| BlackRock, Inc. | 6.80% | 12.14M | 13G | Apr 24, 2026 |
| Vanguard Capital Management | 5.19% | 9.67M | 13G | Jul 31, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Nov 19, 2025 | Katherine Bach Kalindirector | Purchase | 63,400 | $1.59 | 104,400 |
House and Senate disclosures
Not reported.